Selected research
Market Outlook & Growth Opportunities
Global Point-of-care Testing Solution Market Outlook and Growth Opportunities 2026
Market perspective
The global Point-of-care Testing Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Point-of-care Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Point-of-care Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Point-of-care Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Point-of-care Testing Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Point-of-care Testing Solution market include Roche Diagnostics, Abbott, Johnson & Johnson, Siemens Healthineers, Danaher (Beckman Coulter), Ascensia, Sinocare, BioMérieux and QuidelOrtho, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Point-of-care Testing Solution market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Point-of-care Testing Solution and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Point-of-care Testing Solution sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Point-of-care Testing Solution market size, projected growth trends, production technologies, key applications, and end-use industries.
Point-of-care Testing Solution Segment by Company
Roche Diagnostics
Abbott
Johnson & Johnson
Siemens Healthineers
Danaher (Beckman Coulter)
Ascensia
Sinocare
BioMérieux
QuidelOrtho
BD
Nova Biomedical
Werfen
Chembio Diagnostics
Trinity Biotech
Thermo Fisher Scientific
SD Biosensor
Snibe Diagnostics
Wondfo
Yuwell
Runda Medical
Lepu Medical
Getein Biotech
Kehua Bio-engineering
Wuhan EasyDiagnosis Biomedicine
Anda Gene
Point-of-care Testing Solution Segment by Type
Electrochemical Type
Optical Type
Molecular Diagnostics Type
Point-of-care Testing Solution Segment by Application
Hospital
Clinic
R&D
Others
Point-of-care Testing Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Point-of-care Testing Solution status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Point-of-care Testing Solution market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Point-of-care Testing Solution significant trends, drivers, influence factors in global and regions.
6. To analyze Point-of-care Testing Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-care Testing Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-care Testing Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-care Testing Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Point-of-care Testing Solution market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Point-of-care Testing Solution industry.
Chapter 3: Detailed analysis of Point-of-care Testing Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Point-of-care Testing Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Point-of-care Testing Solution in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Point-of-care Testing Solution Industry Trends
Table 2. Point-of-care Testing Solution Industry Drivers
Table 3. Point-of-care Testing Solution Industry Opportunities and Challenges
Table 4. Point-of-care Testing Solution Industry Restraints
Table 5. Global Point-of-care Testing Solution Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Point-of-care Testing Solution Revenue Share by Company (2021-2026)
Table 7. Global Point-of-care Testing Solution Sales Volume by Company (k units) & (2021-2026)
Table 8. Global Point-of-care Testing Solution Sales Volume Share by Company (2021-2026)
Table 9. Global Point-of-care Testing Solution Average Price (USD/unit) of Company (2021-2026)
Table 10. Global Point-of-care Testing Solution Company Ranking, (2024-2026) & (USD Million)
Table 11. Global Point-of-care Testing Solution Key Company Manufacturing Base & Headquarters
Table 12. Global Point-of-care Testing Solution Company, Product Type & Application
Table 13. Global Point-of-care Testing Solution Company Establishment Date
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Point-of-care Testing Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Significant Companies of Electrochemical Type
Table 18. Significant Companies of Optical Type
Table 19. Significant Companies of Molecular Diagnostics Type
Table 20. Global Point-of-care Testing Solution Sales Volume by Type 2021 VS 2025 VS 2032 (k units)
Table 21. Global Point-of-care Testing Solution Sales Volume by Type (2021-2026) & (k units)
Table 22. Global Point-of-care Testing Solution Sales Volume by Type (2027-2032) & (k units)
Table 23. Global Point-of-care Testing Solution Sales Volume Share by Type (2021-2026)
Table 24. Global Point-of-care Testing Solution Sales Volume Share by Type (2027-2032)
Table 25. Global Point-of-care Testing Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Point-of-care Testing Solution Sales Value by Type (2021-2026) & (US$ Million)
Table 27. Global Point-of-care Testing Solution Sales Value by Type (2027-2032) & (US$ Million)
Table 28. Global Point-of-care Testing Solution Sales Value Share by Type (2021-2026)
Table 29. Global Point-of-care Testing Solution Sales Value Share by Type (2027-2032)
Table 30. Significant Companies of Hospital
Table 31. Significant Companies of Clinic
Table 32. Significant Companies of R&D
Table 33. Significant Companies of Others
Table 34. Global Point-of-care Testing Solution Sales Volume by Application 2021 VS 2025 VS 2032 (k units)
Table 35. Global Point-of-care Testing Solution Sales Volume by Application (2021-2026) & (k units)
Table 36. Global Point-of-care Testing Solution Sales Volume by Application (2027-2032) & (k units)
Table 37. Global Point-of-care Testing Solution Sales Volume Share by Application (2021-2026)
Table 38. Global Point-of-care Testing Solution Sales Volume Share by Application (2027-2032)
Table 39. Global Point-of-care Testing Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 40. Global Point-of-care Testing Solution Sales Value by Application (2021-2026) & (US$ Million)
Table 41. Global Point-of-care Testing Solution Sales Value by Application (2027-2032) & (US$ Million)
Table 42. Global Point-of-care Testing Solution Sales Value Share by Application (2021-2026)
Table 43. Global Point-of-care Testing Solution Sales Value Share by Application (2027-2032)
Table 44. Global Point-of-care Testing Solution Sales by Region: 2021 VS 2025 VS 2032 (k units)
Table 45. Global Point-of-care Testing Solution Sales by Region (2021-2026) & (k units)
Table 46. Global Point-of-care Testing Solution Sales Market Share by Region (2021-2026)
Table 47. Global Point-of-care Testing Solution Sales by Region (2027-2032) & (k units)
Table 48. Global Point-of-care Testing Solution Sales Market Share by Region (2027-2032)
Table 49. Global Point-of-care Testing Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 50. Global Point-of-care Testing Solution Sales Value by Region (2021-2026) & (US$ Million)
Table 51. Global Point-of-care Testing Solution Sales Value Share by Region (2021-2026)
Table 52. Global Point-of-care Testing Solution Sales Value by Region (2027-2032) & (US$ Million)
Table 53. Global Point-of-care Testing Solution Sales Value Share by Region (2027-2032)
Table 54. Global Point-of-care Testing Solution Market Average Price (USD/unit) by Region (2021-2026)
Table 55. Global Point-of-care Testing Solution Market Average Price (USD/unit) by Region (2027-2032)
Table 56. Global Point-of-care Testing Solution Sales by Country: 2021 VS 2025 VS 2032 (k units)
Table 57. Global Point-of-care Testing Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 58. Global Point-of-care Testing Solution Sales by Country (2021-2026) & (k units)
Table 59. Global Point-of-care Testing Solution Sales Market Share by Country (2021-2026)
Table 60. Global Point-of-care Testing Solution Sales by Country (2027-2032) & (k units)
Table 61. Global Point-of-care Testing Solution Sales Market Share by Country (2027-2032)
Table 62. Global Point-of-care Testing Solution Sales Value by Country (2021-2026) & (US$ Million)
Table 63. Global Point-of-care Testing Solution Sales Value Market Share by Country (2021-2026)
Table 64. Global Point-of-care Testing Solution Sales Value by Country (2027-2032) & (US$ Million)
Table 65. Global Point-of-care Testing Solution Sales Value Market Share by Country (2027-2032)
Table 66. Roche Diagnostics Company Information
Table 67. Roche Diagnostics Business Overview
Table 68. Roche Diagnostics Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 69. Roche Diagnostics Point-of-care Testing Solution Product Portfolio
Table 70. Roche Diagnostics Recent Development
Table 71. Abbott Company Information
Table 72. Abbott Business Overview
Table 73. Abbott Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 74. Abbott Point-of-care Testing Solution Product Portfolio
Table 75. Abbott Recent Development
Table 76. Johnson & Johnson Company Information
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 79. Johnson & Johnson Point-of-care Testing Solution Product Portfolio
Table 80. Johnson & Johnson Recent Development
Table 81. Siemens Healthineers Company Information
Table 82. Siemens Healthineers Business Overview
Table 83. Siemens Healthineers Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 84. Siemens Healthineers Point-of-care Testing Solution Product Portfolio
Table 85. Siemens Healthineers Recent Development
Table 86. Danaher (Beckman Coulter) Company Information
Table 87. Danaher (Beckman Coulter) Business Overview
Table 88. Danaher (Beckman Coulter) Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 89. Danaher (Beckman Coulter) Point-of-care Testing Solution Product Portfolio
Table 90. Danaher (Beckman Coulter) Recent Development
Table 91. Ascensia Company Information
Table 92. Ascensia Business Overview
Table 93. Ascensia Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 94. Ascensia Point-of-care Testing Solution Product Portfolio
Table 95. Ascensia Recent Development
Table 96. Sinocare Company Information
Table 97. Sinocare Business Overview
Table 98. Sinocare Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 99. Sinocare Point-of-care Testing Solution Product Portfolio
Table 100. Sinocare Recent Development
Table 101. BioMérieux Company Information
Table 102. BioMérieux Business Overview
Table 103. BioMérieux Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 104. BioMérieux Point-of-care Testing Solution Product Portfolio
Table 105. BioMérieux Recent Development
Table 106. QuidelOrtho Company Information
Table 107. QuidelOrtho Business Overview
Table 108. QuidelOrtho Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 109. QuidelOrtho Point-of-care Testing Solution Product Portfolio
Table 110. QuidelOrtho Recent Development
Table 111. BD Company Information
Table 112. BD Business Overview
Table 113. BD Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 114. BD Point-of-care Testing Solution Product Portfolio
Table 115. BD Recent Development
Table 116. Nova Biomedical Company Information
Table 117. Nova Biomedical Business Overview
Table 118. Nova Biomedical Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 119. Nova Biomedical Point-of-care Testing Solution Product Portfolio
Table 120. Nova Biomedical Recent Development
Table 121. Werfen Company Information
Table 122. Werfen Business Overview
Table 123. Werfen Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 124. Werfen Point-of-care Testing Solution Product Portfolio
Table 125. Werfen Recent Development
Table 126. Chembio Diagnostics Company Information
Table 127. Chembio Diagnostics Business Overview
Table 128. Chembio Diagnostics Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 129. Chembio Diagnostics Point-of-care Testing Solution Product Portfolio
Table 130. Chembio Diagnostics Recent Development
Table 131. Trinity Biotech Company Information
Table 132. Trinity Biotech Business Overview
Table 133. Trinity Biotech Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 134. Trinity Biotech Point-of-care Testing Solution Product Portfolio
Table 135. Trinity Biotech Recent Development
Table 136. Thermo Fisher Scientific Company Information
Table 137. Thermo Fisher Scientific Business Overview
Table 138. Thermo Fisher Scientific Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 139. Thermo Fisher Scientific Point-of-care Testing Solution Product Portfolio
Table 140. Thermo Fisher Scientific Recent Development
Table 141. SD Biosensor Company Information
Table 142. SD Biosensor Business Overview
Table 143. SD Biosensor Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 144. SD Biosensor Point-of-care Testing Solution Product Portfolio
Table 145. SD Biosensor Recent Development
Table 146. Snibe Diagnostics Company Information
Table 147. Snibe Diagnostics Business Overview
Table 148. Snibe Diagnostics Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 149. Snibe Diagnostics Point-of-care Testing Solution Product Portfolio
Table 150. Snibe Diagnostics Recent Development
Table 151. Wondfo Company Information
Table 152. Wondfo Business Overview
Table 153. Wondfo Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 154. Wondfo Point-of-care Testing Solution Product Portfolio
Table 155. Wondfo Recent Development
Table 156. Yuwell Company Information
Table 157. Yuwell Business Overview
Table 158. Yuwell Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 159. Yuwell Point-of-care Testing Solution Product Portfolio
Table 160. Yuwell Recent Development
Table 161. Runda Medical Company Information
Table 162. Runda Medical Business Overview
Table 163. Runda Medical Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 164. Runda Medical Point-of-care Testing Solution Product Portfolio
Table 165. Runda Medical Recent Development
Table 166. Lepu Medical Company Information
Table 167. Lepu Medical Business Overview
Table 168. Lepu Medical Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 169. Lepu Medical Point-of-care Testing Solution Product Portfolio
Table 170. Lepu Medical Recent Development
Table 171. Getein Biotech Company Information
Table 172. Getein Biotech Business Overview
Table 173. Getein Biotech Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 174. Getein Biotech Point-of-care Testing Solution Product Portfolio
Table 175. Getein Biotech Recent Development
Table 176. Kehua Bio-engineering Company Information
Table 177. Kehua Bio-engineering Business Overview
Table 178. Kehua Bio-engineering Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 179. Kehua Bio-engineering Point-of-care Testing Solution Product Portfolio
Table 180. Kehua Bio-engineering Recent Development
Table 181. Wuhan EasyDiagnosis Biomedicine Company Information
Table 182. Wuhan EasyDiagnosis Biomedicine Business Overview
Table 183. Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 184. Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Product Portfolio
Table 185. Wuhan EasyDiagnosis Biomedicine Recent Development
Table 186. Anda Gene Company Information
Table 187. Anda Gene Business Overview
Table 188. Anda Gene Point-of-care Testing Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 189. Anda Gene Point-of-care Testing Solution Product Portfolio
Table 190. Anda Gene Recent Development
Table 191. Key Raw Materials
Table 192. Raw Materials Key Suppliers
Table 193. Point-of-care Testing Solution Distributors List
Table 194. Point-of-care Testing Solution Customers List
Table 195. Research Programs/Design for This Report
Table 196. Authors List of This Report
Table 197. Secondary Sources
Table 198. Primary Sources
List of Figures
Figure 1. Point-of-care Testing Solution Product Image
Figure 2. Global Point-of-care Testing Solution Sales Value (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Point-of-care Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 4. Global Point-of-care Testing Solution Sales (2021-2032) & (k units)
Figure 5. Global Point-of-care Testing Solution Sales Average Price (USD/unit) & (2021-2032)
Figure 6. Global Point-of-care Testing Solution Company Revenue Ranking in 2025 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 9. Electrochemical Type Image
Figure 10. Optical Type Image
Figure 11. Molecular Diagnostics Type Image
Figure 12. Global Point-of-care Testing Solution Sales Volume by Type (2021 VS 2025 VS 2032) & (k units)
Figure 13. Global Point-of-care Testing Solution Sales Volume Share 2021 VS 2025 VS 2032
Figure 14. Global Point-of-care Testing Solution Sales Volume Share by Type (2021-2032)
Figure 15. Global Point-of-care Testing Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 16. Global Point-of-care Testing Solution Sales Value Share 2021 VS 2025 VS 2032
Figure 17. Global Point-of-care Testing Solution Sales Value Share by Type (2021-2032)
Figure 18. Hospital Image
Figure 19. Clinic Image
Figure 20. R&D Image
Figure 21. Others Image
Figure 22. Global Point-of-care Testing Solution Sales Volume by Application (2021 VS 2025 VS 2032) & (k units)
Figure 23. Global Point-of-care Testing Solution Sales Volume Share 2021 VS 2025 VS 2032
Figure 24. Global Point-of-care Testing Solution Sales Volume Share by Application (2021-2032)
Figure 25. Global Point-of-care Testing Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 26. Global Point-of-care Testing Solution Sales Value Share 2021 VS 2025 VS 2032
Figure 27. Global Point-of-care Testing Solution Sales Value Share by Application (2021-2032)
Figure 28. Global Point-of-care Testing Solution Sales by Region: 2021 VS 2025 VS 2032 (k units)
Figure 29. Global Point-of-care Testing Solution Sales Market Share by Region: 2021 VS 2025 VS 2032
Figure 30. Global Point-of-care Testing Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 31. Global Point-of-care Testing Solution Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 32. North America Point-of-care Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 33. North America Point-of-care Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 34. Europe Point-of-care Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 35. Europe Point-of-care Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 36. Asia-Pacific Point-of-care Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Point-of-care Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 38. South America Point-of-care Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 39. South America Point-of-care Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 40. Middle East & Africa Point-of-care Testing Solution Sales Value (2021-2032) & (US$ Million)
Figure 41. Middle East & Africa Point-of-care Testing Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 42. USA Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. USA Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. USA Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. Canada Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. Canada Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. Canada Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. Mexico Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. Mexico Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. Mexico Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Germany Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Germany Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Germany Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. France Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. France Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. France Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. U.K. Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. U.K. Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. U.K. Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Italy Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Italy Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Italy Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Spain Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Spain Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Spain Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. Russia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. Russia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. Russia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. Netherlands Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. Netherlands Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. Netherlands Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. Nordic Countries Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. Nordic Countries Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. Nordic Countries Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. China Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. China Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. China Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Japan Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Japan Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Japan Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. South Korea Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. South Korea Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. South Korea Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. India Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. India Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. India Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Australia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Australia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Australia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Southeast Asia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Southeast Asia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Southeast Asia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Brazil Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Brazil Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Brazil Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Argentina Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Argentina Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Argentina Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Chile Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Chile Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Chile Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Colombia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Colombia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Colombia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. Peru Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. Peru Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. Peru Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Saudi Arabia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Saudi Arabia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Saudi Arabia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Israel Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Israel Arabia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Israel Arabia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. UAE Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. UAE Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. UAE Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Turkey Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 118. Turkey Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 119. Turkey Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 120. Iran Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 121. Iran Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 122. Iran Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 123. Egypt Point-of-care Testing Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 124. Egypt Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 125. Egypt Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 126. Point-of-care Testing Solution Value Chain
Figure 127. Manufacturing Cost Structure
Figure 128. Point-of-care Testing Solution Sales Mode & Process
Figure 129. Direct Comparison with Distribution Share
Figure 130. Distributors Profiles
Figure 131. Years Considered
Figure 132. Research Process
Figure 133. Key Executives Interviewed
Scope & coverage.
Types
- Electrochemical Type
- Optical Type
- Molecular Diagnostics Type
Applications
- Hospital
- Clinic
- R&D
- Others
Companies covered
- Roche Diagnostics
- Abbott
- Johnson & Johnson
- Siemens Healthineers
- Danaher (Beckman Coulter)
- Ascensia
- Sinocare
- BioMérieux
- QuidelOrtho
- BD
- Nova Biomedical
- Werfen
- Chembio Diagnostics
- Trinity Biotech
- Thermo Fisher Scientific
- SD Biosensor
- Snibe Diagnostics
- Wondfo
- Yuwell
- Runda Medical
- Lepu Medical
- Getein Biotech
- Kehua Bio-engineering
- Wuhan EasyDiagnosis Biomedicine
- Anda Gene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Point-of-care Testing Solution Sales Value (2021-2032)
- 1.2.2 Global Point-of-care Testing Solution Sales Volume (2021-2032)
- 1.2.3 Global Point-of-care Testing Solution Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Point-of-care Testing Solution Market Dynamics
- 2.1 Point-of-care Testing Solution Industry Trends
- 2.2 Point-of-care Testing Solution Industry Drivers
- 2.3 Point-of-care Testing Solution Industry Opportunities and Challenges
- 2.4 Point-of-care Testing Solution Industry Restraints
3 Point-of-care Testing Solution Market by Company
- 3.1 Global Point-of-care Testing Solution Company Revenue Ranking in 2025
- 3.2 Global Point-of-care Testing Solution Revenue by Company (2021-2026)
- 3.3 Global Point-of-care Testing Solution Sales Volume by Company (2021-2026)
- 3.4 Global Point-of-care Testing Solution Average Price by Company (2021-2026)
- 3.5 Global Point-of-care Testing Solution Company Ranking (2024-2026)
- 3.6 Global Point-of-care Testing Solution Company Manufacturing Base and Headquarters
- 3.7 Global Point-of-care Testing Solution Company Product Type and Application
- 3.8 Global Point-of-care Testing Solution Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Point-of-care Testing Solution Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Point-of-care Testing Solution Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Point-of-care Testing Solution Market by Type
- 4.1 Point-of-care Testing Solution Type Introduction
- 4.1.1 Electrochemical Type
- 4.1.2 Optical Type
- 4.1.3 Molecular Diagnostics Type
- 4.2 Global Point-of-care Testing Solution Sales Volume by Type
- 4.2.1 Global Point-of-care Testing Solution Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Point-of-care Testing Solution Sales Volume by Type (2021-2032)
- 4.2.3 Global Point-of-care Testing Solution Sales Volume Share by Type (2021-2032)
- 4.3 Global Point-of-care Testing Solution Sales Value by Type
- 4.3.1 Global Point-of-care Testing Solution Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Point-of-care Testing Solution Sales Value by Type (2021-2032)
- 4.3.3 Global Point-of-care Testing Solution Sales Value Share by Type (2021-2032)
5 Point-of-care Testing Solution Market by Application
- 5.1 Point-of-care Testing Solution Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 R&D
- 5.1.4 Others
- 5.2 Global Point-of-care Testing Solution Sales Volume by Application
- 5.2.1 Global Point-of-care Testing Solution Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Point-of-care Testing Solution Sales Volume by Application (2021-2032)
- 5.2.3 Global Point-of-care Testing Solution Sales Volume Share by Application (2021-2032)
- 5.3 Global Point-of-care Testing Solution Sales Value by Application
- 5.3.1 Global Point-of-care Testing Solution Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Point-of-care Testing Solution Sales Value by Application (2021-2032)
- 5.3.3 Global Point-of-care Testing Solution Sales Value Share by Application (2021-2032)
6 Point-of-care Testing Solution Regional Sales and Value Analysis
- 6.1 Global Point-of-care Testing Solution Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Point-of-care Testing Solution Sales by Region (2021-2032)
- 6.2.1 Global Point-of-care Testing Solution Sales by Region: 2021-2026
- 6.2.2 Global Point-of-care Testing Solution Sales by Region (2027-2032)
- 6.3 Global Point-of-care Testing Solution Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Point-of-care Testing Solution Sales Value by Region (2021-2032)
- 6.4.1 Global Point-of-care Testing Solution Sales Value by Region: 2021-2026
- 6.4.2 Global Point-of-care Testing Solution Sales Value by Region (2027-2032)
- 6.5 Global Point-of-care Testing Solution Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Point-of-care Testing Solution Sales Value (2021-2032)
- 6.6.2 North America Point-of-care Testing Solution Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Point-of-care Testing Solution Sales Value (2021-2032)
- 6.7.2 Europe Point-of-care Testing Solution Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Point-of-care Testing Solution Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Point-of-care Testing Solution Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Point-of-care Testing Solution Sales Value (2021-2032)
- 6.9.2 South America Point-of-care Testing Solution Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Point-of-care Testing Solution Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Point-of-care Testing Solution Sales Value Share by Country, 2025 VS 2032
7 Point-of-care Testing Solution Country-level Sales and Value Analysis
- 7.1 Global Point-of-care Testing Solution Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Point-of-care Testing Solution Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Point-of-care Testing Solution Sales by Country (2021-2032)
- 7.3.1 Global Point-of-care Testing Solution Sales by Country (2021-2026)
- 7.3.2 Global Point-of-care Testing Solution Sales by Country (2027-2032)
- 7.4 Global Point-of-care Testing Solution Sales Value by Country (2021-2032)
- 7.4.1 Global Point-of-care Testing Solution Sales Value by Country (2021-2026)
- 7.4.2 Global Point-of-care Testing Solution Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.9.2 France Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.16.2 China Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.19.2 India Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Point-of-care Testing Solution Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Point-of-care Testing Solution Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Point-of-care Testing Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Roche Diagnostics
- 8.1.1 Roche Diagnostics Company Information
- 8.1.2 Roche Diagnostics Business Overview
- 8.1.3 Roche Diagnostics Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Roche Diagnostics Point-of-care Testing Solution Product Portfolio
- 8.1.5 Roche Diagnostics Recent Developments
- 8.2 Abbott
- 8.2.1 Abbott Company Information
- 8.2.2 Abbott Business Overview
- 8.2.3 Abbott Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Abbott Point-of-care Testing Solution Product Portfolio
- 8.2.5 Abbott Recent Developments
- 8.3 Johnson & Johnson
- 8.3.1 Johnson & Johnson Company Information
- 8.3.2 Johnson & Johnson Business Overview
- 8.3.3 Johnson & Johnson Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Johnson & Johnson Point-of-care Testing Solution Product Portfolio
- 8.3.5 Johnson & Johnson Recent Developments
- 8.4 Siemens Healthineers
- 8.4.1 Siemens Healthineers Company Information
- 8.4.2 Siemens Healthineers Business Overview
- 8.4.3 Siemens Healthineers Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Siemens Healthineers Point-of-care Testing Solution Product Portfolio
- 8.4.5 Siemens Healthineers Recent Developments
- 8.5 Danaher (Beckman Coulter)
- 8.5.1 Danaher (Beckman Coulter) Company Information
- 8.5.2 Danaher (Beckman Coulter) Business Overview
- 8.5.3 Danaher (Beckman Coulter) Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Danaher (Beckman Coulter) Point-of-care Testing Solution Product Portfolio
- 8.5.5 Danaher (Beckman Coulter) Recent Developments
- 8.6 Ascensia
- 8.6.1 Ascensia Company Information
- 8.6.2 Ascensia Business Overview
- 8.6.3 Ascensia Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Ascensia Point-of-care Testing Solution Product Portfolio
- 8.6.5 Ascensia Recent Developments
- 8.7 Sinocare
- 8.7.1 Sinocare Company Information
- 8.7.2 Sinocare Business Overview
- 8.7.3 Sinocare Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Sinocare Point-of-care Testing Solution Product Portfolio
- 8.7.5 Sinocare Recent Developments
- 8.8 BioMérieux
- 8.8.1 BioMérieux Company Information
- 8.8.2 BioMérieux Business Overview
- 8.8.3 BioMérieux Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.8.4 BioMérieux Point-of-care Testing Solution Product Portfolio
- 8.8.5 BioMérieux Recent Developments
- 8.9 QuidelOrtho
- 8.9.1 QuidelOrtho Company Information
- 8.9.2 QuidelOrtho Business Overview
- 8.9.3 QuidelOrtho Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.9.4 QuidelOrtho Point-of-care Testing Solution Product Portfolio
- 8.9.5 QuidelOrtho Recent Developments
- 8.10 BD
- 8.10.1 BD Company Information
- 8.10.2 BD Business Overview
- 8.10.3 BD Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.10.4 BD Point-of-care Testing Solution Product Portfolio
- 8.10.5 BD Recent Developments
- 8.11 Nova Biomedical
- 8.11.1 Nova Biomedical Company Information
- 8.11.2 Nova Biomedical Business Overview
- 8.11.3 Nova Biomedical Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Nova Biomedical Point-of-care Testing Solution Product Portfolio
- 8.11.5 Nova Biomedical Recent Developments
- 8.12 Werfen
- 8.12.1 Werfen Company Information
- 8.12.2 Werfen Business Overview
- 8.12.3 Werfen Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Werfen Point-of-care Testing Solution Product Portfolio
- 8.12.5 Werfen Recent Developments
- 8.13 Chembio Diagnostics
- 8.13.1 Chembio Diagnostics Company Information
- 8.13.2 Chembio Diagnostics Business Overview
- 8.13.3 Chembio Diagnostics Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Chembio Diagnostics Point-of-care Testing Solution Product Portfolio
- 8.13.5 Chembio Diagnostics Recent Developments
- 8.14 Trinity Biotech
- 8.14.1 Trinity Biotech Company Information
- 8.14.2 Trinity Biotech Business Overview
- 8.14.3 Trinity Biotech Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Trinity Biotech Point-of-care Testing Solution Product Portfolio
- 8.14.5 Trinity Biotech Recent Developments
- 8.15 Thermo Fisher Scientific
- 8.15.1 Thermo Fisher Scientific Company Information
- 8.15.2 Thermo Fisher Scientific Business Overview
- 8.15.3 Thermo Fisher Scientific Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Thermo Fisher Scientific Point-of-care Testing Solution Product Portfolio
- 8.15.5 Thermo Fisher Scientific Recent Developments
- 8.16 SD Biosensor
- 8.16.1 SD Biosensor Company Information
- 8.16.2 SD Biosensor Business Overview
- 8.16.3 SD Biosensor Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.16.4 SD Biosensor Point-of-care Testing Solution Product Portfolio
- 8.16.5 SD Biosensor Recent Developments
- 8.17 Snibe Diagnostics
- 8.17.1 Snibe Diagnostics Company Information
- 8.17.2 Snibe Diagnostics Business Overview
- 8.17.3 Snibe Diagnostics Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Snibe Diagnostics Point-of-care Testing Solution Product Portfolio
- 8.17.5 Snibe Diagnostics Recent Developments
- 8.18 Wondfo
- 8.18.1 Wondfo Company Information
- 8.18.2 Wondfo Business Overview
- 8.18.3 Wondfo Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Wondfo Point-of-care Testing Solution Product Portfolio
- 8.18.5 Wondfo Recent Developments
- 8.19 Yuwell
- 8.19.1 Yuwell Company Information
- 8.19.2 Yuwell Business Overview
- 8.19.3 Yuwell Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Yuwell Point-of-care Testing Solution Product Portfolio
- 8.19.5 Yuwell Recent Developments
- 8.20 Runda Medical
- 8.20.1 Runda Medical Company Information
- 8.20.2 Runda Medical Business Overview
- 8.20.3 Runda Medical Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Runda Medical Point-of-care Testing Solution Product Portfolio
- 8.20.5 Runda Medical Recent Developments
- 8.21 Lepu Medical
- 8.21.1 Lepu Medical Company Information
- 8.21.2 Lepu Medical Business Overview
- 8.21.3 Lepu Medical Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.21.4 Lepu Medical Point-of-care Testing Solution Product Portfolio
- 8.21.5 Lepu Medical Recent Developments
- 8.22 Getein Biotech
- 8.22.1 Getein Biotech Company Information
- 8.22.2 Getein Biotech Business Overview
- 8.22.3 Getein Biotech Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Getein Biotech Point-of-care Testing Solution Product Portfolio
- 8.22.5 Getein Biotech Recent Developments
- 8.23 Kehua Bio-engineering
- 8.23.1 Kehua Bio-engineering Company Information
- 8.23.2 Kehua Bio-engineering Business Overview
- 8.23.3 Kehua Bio-engineering Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.23.4 Kehua Bio-engineering Point-of-care Testing Solution Product Portfolio
- 8.23.5 Kehua Bio-engineering Recent Developments
- 8.24 Wuhan EasyDiagnosis Biomedicine
- 8.24.1 Wuhan EasyDiagnosis Biomedicine Company Information
- 8.24.2 Wuhan EasyDiagnosis Biomedicine Business Overview
- 8.24.3 Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Product Portfolio
- 8.24.5 Wuhan EasyDiagnosis Biomedicine Recent Developments
- 8.25 Anda Gene
- 8.25.1 Anda Gene Company Information
- 8.25.2 Anda Gene Business Overview
- 8.25.3 Anda Gene Point-of-care Testing Solution Sales, Value and Gross Margin (2021-2026)
- 8.25.4 Anda Gene Point-of-care Testing Solution Product Portfolio
- 8.25.5 Anda Gene Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Point-of-care Testing Solution Value Chain Analysis
- 9.1.1 Point-of-care Testing Solution Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Point-of-care Testing Solution Sales Mode & Process
- 9.2 Point-of-care Testing Solution Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Point-of-care Testing Solution Distributors
- 9.2.3 Point-of-care Testing Solution Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst